HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.

AuthorsYuriko Yamamoto, Noriaki Nakai, Yusuke Wakabayashi, Yasutaro Okuzawa, Jun Asai, Hideya Takenaka, Norito Katoh
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 67 Issue 5 Pg. e233-4 (Nov 2012) ISSN: 1097-6787 [Electronic] United States
PMID23062933 (Publication Type: Case Reports, Letter)
Chemical References
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
Topics
  • Administration, Oral
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Carcinoma, Squamous Cell (drug therapy, pathology)
  • Drug Combinations
  • Eyelid Neoplasms (drug therapy, pathology)
  • Female
  • Head and Neck Neoplasms (drug therapy, pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm Invasiveness
  • Oxonic Acid (administration & dosage)
  • Skin Neoplasms (drug therapy, pathology)
  • Squamous Cell Carcinoma of Head and Neck
  • Tegafur (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: